These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32761959)

  • 61. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Denosumab in the management of Aneurysmal bone cyst.
    Maximen J; Robin F; Tronchot A; Rossetti A; Ropars M; Guggenbuhl P
    Joint Bone Spine; 2022 Jan; 89(1):105260. PubMed ID: 34481945
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
    Meyers PA; Heller G; Vlamis V
    Cancer Treat Res; 1993; 62():309-22. PubMed ID: 7682091
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
    Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
    Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
    J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
    [TBL] [Abstract][Full Text] [Related]  

  • 66. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome.
    Laux CJ; Berzaczy G; Weber M; Lang S; Dominkus M; Windhager R; Nöbauer-Huhmann IM; Funovics PT
    Int Orthop; 2015 Jan; 39(1):97-104. PubMed ID: 25432323
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.
    Lindner NJ; Scarborough MT; Spanier SS; Enneking WF
    J Cancer Res Clin Oncol; 1998; 124(10):575-80. PubMed ID: 9829862
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Present status of the chemotherapy of malignant bone tumors].
    Yamawaki S
    Nihon Seikeigeka Gakkai Zasshi; 1992 Jan; 66(1):126-36. PubMed ID: 1548438
    [No Abstract]   [Full Text] [Related]  

  • 71. Delaying surgery with chemotherapy for osteosarcoma of the extremities.
    Bielack SS; Machatschek JN; Flege S; Jürgens H
    Expert Opin Pharmacother; 2004 Jun; 5(6):1243-56. PubMed ID: 15163270
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study.
    Bacci G; Ferrari S; Longhi A; Picci P; Mercuri M; Alvegard TA; Saeter G; Donati D; Manfrini M; Lari S; Briccoli A; Forni C;
    J Chemother; 2002 Apr; 14(2):198-206. PubMed ID: 12017378
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Malignant bone tumours in children and adolescent].
    Bollini G; Kalifa C; Panuel M
    Arch Pediatr; 2006 Jun; 13(6):669-71. PubMed ID: 16697603
    [No Abstract]   [Full Text] [Related]  

  • 74. Aneurysmal bone cyst secondary to giant cell tumor of the mobile spine: a report of 11 cases.
    Wu Z; Yang X; Xiao J; Feng D; Huang Q; Zheng W; Huang W; Zhou Z
    Spine (Phila Pa 1976); 2011 Oct; 36(21):E1385-90. PubMed ID: 21221054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
    Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
    Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
    Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
    Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Simulation of teleangiectactic osteosarcoma by aneurysmatic bone cyst].
    Do TD; Renker EK; Weber MA
    Orthopade; 2013 Dec; 42(12):1067-70. PubMed ID: 24337363
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
    Pratt CB; Epelman S; Jaffe N
    Cancer Treat Rep; 1987 Apr; 71(4):421-3. PubMed ID: 2435408
    [No Abstract]   [Full Text] [Related]  

  • 79. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
    Bacci G; Ferrari S; Delepine N; Bertoni F; Picci P; Mercuri M; Bacchini P; Brach del Prever A; Tienghi A; Comandone A; Campanacci M
    J Clin Oncol; 1998 Feb; 16(2):658-63. PubMed ID: 9469355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
    Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
    Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.